Interlock Device for Impaired Drivers
Sponsored By: Amy Paschal (Democratic), Dylan Roberts (Democratic), Jamie Jackson (Democratic)
Introduced
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & Cosponsors
Sponsors
Amy Paschal
Democratic • House
Dylan Roberts
Democratic • Senate
Jamie Jackson
Democratic • House
Cosponsors
Andrew Boesenecker
Democratic • House
Bob Marshall
Democratic • House
Chad Clifford
Democratic • House
Emily Sirota
Democratic • House
Kenny Nguyen
Democratic • House
Monica Duran
Democratic • House
Meg Froelich
Democratic • House
Mandy Lindsay
Democratic • House
Manny Rutinel
Democratic • House
Roll Call Votes
No roll call votes available for this bill.
Actions Timeline
Senate Committee on Transportation & Energy Refer Unamended to Appropriations
4/6/2026SenateIntroduced In Senate - Assigned to Transportation & Energy
3/30/2026SenateHouse Third Reading Passed - No Amendments
3/25/2026HouseHouse Second Reading Special Order - Passed with Amendments - Committee
3/24/2026HouseHouse Second Reading Passed with Amendments - Committee
3/24/2026HouseHouse Committee on Appropriations Refer Amended to House Committee of the Whole
3/20/2026HouseHouse Committee on Transportation, Housing & Local Government Refer Amended to Appropriations
3/11/2026HouseIntroduced In House - Assigned to Transportation, Housing & Local Government
2/18/2026House
Bill Text
Engrossed
Introduced
PA1
PA2
Reengrossed
Related Bills
HB26-1133 — Traveling Animal Protection Act Environmental Education Program
SB26-021 — Clean Fleet Enterprise Replace Aging Diesel Trucks
SB26-110 — Revised Public Assistance Final Disposition Expense Terms
SB26-126 — Licensure for Experienced Out-of-State Teachers
SB26-031 — Use of Prescription Product with Controlled Substance
SB26-077 — Epilepsy-Related Mortality Awareness